GB Sciences Surpasses Key Corporate Milestones, Plus Exclusive CEO Interview -- CFN Media

SEATTLE, WA--(Marketwired - May 2, 2017) - CFN Media Group ("CannabisFN"), the leading creative agency and media network dedicated to legal cannabis, announces publication of an article and interview with CEO John Poss, discussing GB Sciences Inc.'s (OTCQB: GBLX) recent developments and its strategy moving forward.

Innovative New Products & Partners

GB Sciences recently signed an agreement with Kush Cups to produce Keurig-compatible K-Cups in the State of Nevada. These K-Cups can be used by medical marijuana -- and soon recreational marijuana -- consumers to brew hot and cold coffees and teas. Consumers may find these kinds of products easier for consuming cannabinoids compared to other common forms of consumption, such as smoking, cannabis oils, or edible products.

The company will leverage its advanced propagation technology, tissue culture, and medical-grade clean rooms to grow cannabis in their state-of-the-art cultivation facility in Las Vegas and distribute the Kush Cups throughout the state. Consistency is especially important for medical marijuana consumers that rely on specific combinations of cannabidiol (CBD), tetrahydrocannabinol (THC), and other beneficial cannabinoids.

K-Cups also provide a compelling revenue model for the two partners. The daily use disposable products provide a great source for recurring revenue, while the ubiquity of Keurig machines means a large potential target market. Kush Cups has become a leading provider of cannabis products in the State of Nevada with the potential to expand into other states throughout the country over the long-term.

Growing Op & Research Opportunities

GB Sciences will complete its first marijuana harvest over the coming weeks at its Las Vegas cultivation facility. In addition to this production, the company recently acquired two other Nevada licenses that will be folded into the production facility and expand the scope of its business to include oil extraction, production, and other services. Management also aims to acquire a license in California within the next 12 months to add to its capacity.

In early April, the company submitted an offer to Louisiana State University to act as a licensed operator of its medical cannabis production facility under the Alison Neustrom Act. The deal would enable the company to be the sole vendor of cannabis and extracts on behalf of LSU for the patients of Louisiana. LSU and Southern University have the only two licenses granted by the state to cultivate, distribute, and sell medical cannabis.

The Act also authorized LSU AgCenter to conduct research on medical cannabis, which could tie in nicely with GB Sciences' research-driven efforts. The research division would work alongside the facility to produce therapeutic medical cannabis products for qualified patients. If GB Sciences wins the contract, it will have the first right to commercialize any inventions or discovery of research from the institution.

Please follow the link to read the full article and see the CEO interview: http://www.cannabisfn.com/gb-sciences-surpasses-key-corporate-milestones/

Learn how to become a CFN Media client company, brand or entrepreneur: http://www.cannabisfn.com/become-featured-company/

Download the CFN Media iOS mobile app to access the world of cannabis from the palm of your hand: https://itunes.apple.com/us/app/cannabisfn/id988009247?ls=1&mt=8

Or visit our homepage and enter your mobile number under the Apple App Store logo to receive a download link text on your iPhone: http://www.cannabisfn.com

About CFN Media

CFN Media (CannabisFN) is the leading creative agency and media network dedicated to legal cannabis. We help marijuana businesses attract investors, customers (B2B, B2C), capital, and media visibility. Private and public marijuana companies and brands in the US and Canada rely on CFN Media to grow and succeed.

Disclaimer:

Except for the historical information presented herein, matters discussed in this release contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. Emerging Growth LLC, which owns CFN Media and CannabisFN.com, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. Emerging Growth LLC may from time to time have a position in the securities mentioned herein and may increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice. Emerging Growth LLC may be compensated for its services in the form of cash-based compensation or equity securities in the companies it writes about, or a combination of the two. For full disclosure please visit: http://www.cannabisfn.com/legal-disclaimer/.